The prevalence of hyperhomocysteinemia (> 15 µmol/L) was 56.38% in arterial occlusive disease and 54.64% in venous thrombosis. In patients with peripheral vascular occlusive disease, patients ...

There are a paucity of data in the literature regarding the natural history in patients with subclavian artery occlusive disease. The left subclavian artery is more frequently involved than the ...

Leg pain and leg cramps aren't always an orthopedic issue: Both can be signs of peripheral artery disease, or PAD, a serious blood-flow issue with implications for the heart. In this expert alert ...

The interventional approach to treat peripheral artery occlusive disease (PAOD) as a treatment of choice is gaining continuous acceptance. SeQuent ® Please OTW offers a targeted, polymer-free and ...

Finnish biopharmaceutical company Aplagon has secured a financing of €7m ($7.24m) to advance its heparin proteoglycan mimetic, APAC, to primarily support the initiation of a Phase IIa trial for ...

HONOLULU (KHON2) — Peripheral Artery Disease is a common condition that causes leg pain and weakness. The disease is a narrowing or blockage in the legs and it is most often a chronic condition.

AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early ...

Beyond hypertension, we did not implement other exclusion criteria to exclude arterial obstructions or explicitly screen for subjects with cardiac valvular disease or murmurs. In this study, we ...

Bentley’s BeFlow Covered Stent for Iliac Occlusive Diseases Launched in Europe January 28 ... sirolimus-coated balloon in the treatment of peripheral artery disease (PAD). R3 Vascular Secures WCG IRB ...

Helsinki-based Aplagon has raised EUR 7 million to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2a clinical trials. Aki Prihti, CEO of Aplagon, said: “We’re delighted to ...

Below-the-knee (BTK) arterial disease represents a significant challenge in peripheral artery disease (PAD) management, particularly in patients with chronic limb-threatening ischemia (CLTI). CLTI ...

Peripheral artery disease (PAD) is a long-term condition describing impaired blood flow to the limbs, typically the legs. In 2019 approximately 237M people were living with PAD worldwide; however, ...